OECDReference EN/AU/PS1096548
Fiasp FlexTouch
Official information organised for easier consultation. The source publication remains authoritative.
Identification
Product identification
- Product
- Fiasp FlexTouch
- Official identifiers
- EAN: 9324627002119
Official information
Risk and measures
- Risk or hazard
- The storage instructions inside the product has incorrect labelling. The pack insert incorrectly states: ‘Do not keep the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. The storage conditions are correctly stated on the product carton. The correct statement reads: ‘You can carry the Fiasp® FlexTouch® that you are using, or that you are carrying as a spare, with you. You can keep it at room temperature (not above 30°C) or in a refrigerator (2°C - 8°C) for up to 4 weeks.’ Storing the product at incorrect temperatures may result in reduced effectiveness, which may increase the risk of adverse health effects.
- Recommendations
- Consumers should follow the instructions on the carton which indicate you can carry the Fiasp® FlexTouch® you are using, or carrying as a spare, either below 30°C or in a refrigerator (2°C - 8°C). Consumers can obtain a current Consumer Medicine Information leaflet from a pharmacist or visit the TGA website at https://www.ebs.tga.gov.au/ For further information, contact NovoNordisk Customer Service by phone on 1800 668 626.
Official information
Economic operators
- Manufacturer
- Novo Nordisk Pharmaceuticals Pty Ltd
Territory
Geography
- Origin
- Denmark
- Distribution
- Retirada en Australia
- Country of recall
- Australia
Provenance and context
NagameAlert distinguishes content published by the source from its organisation and normalisation. Values marked “NagameAlert” belong to that processing layer. Always check measures, scope and updates in the official publication.